Current Drug Targets, Volume 18 - Number 7


Meet Our Editorial Board Member

, 18(7): 751

Chen Chen

DOI: 10.2174/138945011807170428181919


Editorial: New Therapies, Markers and Therapeutic Targets in HCV Chronic Infection and HCV Extrahepatic Manifestations

, 18(7): 752 - 755

Alessandro Antonelli and Mauro Pistello

DOI: 10.2174/1389450116666151102095708

Review Article

The Role of MicroRNA in Pathogenesis and as Markers of HCV Chronic Infection

, 18(7): 756 - 765

Chang Ho Lee, Ji Hyun Kim and Seong-Wook Lee

DOI: 10.2174/1389450117666160401125213

Review Article

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges

, 18(7): 766 - 771

Sabino Russi, Loredana Sansonno and Domenico Sansonno

DOI: 10.2174/1389450117666160201112525

Review Article

Virological and Clinical Response to Interferon-Free Regimens in Patients with HCV-Related Mixed Cryoglobulinemia: Preliminary Results of a Prospective Pilot Study

, 18(7): 772 - 785

Laura Gragnani, Alessia Piluso, Teresa Urraro, Alessio Fabbrizzi, Elisa Fognani, Luisa Petraccia, Alessandro Genovesi, Lidia Giubilei, Jessica Ranieri, Cristina Stasi, Monica Monti and Anna Linda Zignego

DOI: 10.2174/1389450117666160208145432

Review Article

Chemokines in the Pathogenesis and as Therapeutical Markers and Targets of HCV Chronic Infection and HCV Extrahepatic Manifestations

, 18(7): 786 - 793

Poupak Fallahi, Silvia Martina Ferrari, Dilia Giuggioli, Marco Sebastiani, Michele Colaci, Clodoveo Ferri and Alessandro Antonelli

DOI: 10.2174/1389450116666150804105937

Review Article

Treatment of HCV-Related Mixed Cryoglobulinemia

, 18(7): 794 - 802

Dilia Giuggioli, Marco Sebastiani, Michele Colaci, Poupak Fallahi, Laura Gragnani, Anna Linda Zignego, Alessandro Antonelli and Clodoveo Ferri

DOI: 10.2174/1389450116666150825112105

Review Article

HCV-Related Rheumatic Manifestations and Therapeutic Strategies

, 18(7): 803 - 810

Marco Sebastiani, Dilia Giuggioli, Michele Colaci, Poupak Fallahi, Laura Gragnani, Alessandro Antonelli, Anna Linda Zignego and Clodoveo Ferri

DOI: 10.2174/1389450116666150907103622

Review Article

How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection?

, 18(7): 811 - 825

Fabrizio Maggi, Daniele Focosi and Mauro Pistello

DOI: 10.2174/1389450116666150806123119

Review Article

Innate and Adaptive Immune Responses in Chronic HCV Infection

, 18(7): 826 - 843

Lynn B. Dustin

DOI: 10.2174/1389450116666150825110532

Review Article

Role of Interferons in Chronic Hepatitis C Infection

, 18(7): 844 - 850

Carolina Scagnolari, Katia Monteleone, Giulia Cacciotti and Guido Antonelli

DOI: 10.2174/1389450117666160201112632

Review Article

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues

, 18(7): 851 - 862

Jordan J. Feld

DOI: 10.2174/1389450116666150825111314

Review Article

The Two Faces of Interleukin-17A in Atherosclerosis

, 18(7): 863 - 873

Mohammadreza Akhavanpoor, Hamidreza Akhavanpoor, Christian A. Gleissner, Susanne Wangler, Andreas O. Doesch, Hugo A. Katus and Christian Erbel

DOI: 10.2174/1389450117666161229142155

Review Article

Review of the Third Domain Receptor Binding Fragment of Alphafetoprotein (AFP): Plausible Binding of AFP to Lysophospholipid Receptor Targets

, 18(7): 874 - 886

Gerald J. Mizejewski

DOI: 10.2174/1389450117666160201105245

Webmaster Contact:
Copyright © 2018 Bentham Science